Bevacizumab, Gemcitabine, and Oxaliplatin in Treating Patients With Metastatic Pancreatic Cancer

NCT00112528 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

53

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Cancer

Interventions

BIOLOGICAL: bevacizumab
DRUG: gemcitabine hydrochloride
DRUG: oxaliplatin

Sponsor

Alliance for Clinical Trials in Oncology

Collaborators

[object Object]